GGrantIndex
Sort

27,075 grants matching cholesterol

Joint Patient and Caregiver Intervention for Older African Americans with Poorly Controlled Type 2 Diabetes (Joint Home-DM-BAT)

$597,015
Aprill Dawson · Medical College Of Wisconsin · R21 · FY2023 · DK

Restriction of Toxoplasma growth in human cells

$596,966
Jeroen Saeij · University Of California At Davis · R01 · FY2025 · AI

Role of ABCG5 and ABCG8 in Sterol Metabolism

$596,938
Helen H. Hobbs · Ut Southwestern Medical Center · R01 · FY2019 · HL

Role of ABCG5 and ABCG8 in Sterol Metabolism

$596,938
Helen H. Hobbs · Ut Southwestern Medical Center · R01 · FY2021 · HL

HIT for Facilitating Problem Solving in Diabetes Management

$596,712
George M. Hripcsak · Columbia University Health Sciences · R01 · FY2013 · DK

ACES - ACE inhibitors Combined with Exercise for hypertensive Seniors

$596,690
Thomas W Buford · University Of Alabama At Birmingham · R01 · FY2018 · AG

Cholesterol and inflammation Lowering via BEmpedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

$596,450
Priscilla Y. Hsue · University Of California Los Angeles · R01 · FY2024 · HL

Novel Transgenic Rabbit Model for Cardiovascular Disease

$596,411
Fuliang Du · Evergen Biotechnologies, Inc. · R44 · FY2008 · HL

Exercise and Nicotine Replacement for Female Smokers

$596,139
Taru Kinnunen · Harvard Medical School · R01 · FY2007 · DA

A Personalized Metabolomic Approach to Human Obesity and Weight Loss

$596,091
Svati H. Shah · Duke University · R01 · FY2017 · HL

Genetic Repair of Familial Hypercholesterolemia

$596,073
William Raymond Lagor · Baylor College Of Medicine · R01 · FY2017 · HL

Strong Hearts_Healthy Communities_A Rural Community CVD Prevention Program

$595,905
Rebecca Anne Seguin-Fowler · Cornell University · R01 · FY2016 · HL

Impact of phosphate and FGF23 reduction on intermediate end points in CKD

$595,878
Tamara Isakova · Northwestern University At Chicago · R01 · FY2015 · DK

Designed Small Molecule Inhibitors of Ghrelin O-Acyl Transferase

$595,852
Patrick G. Harran · University Of California Los Angeles · R01 · FY2015 · DK

Project 1 - Changes in Gut Microbiome and related Metabolome Across Trajectory of Alzheimer's Disease

$595,839
Rima F Kaddurah-Daouk · Duke University · U19 · FY2019 · AG

SOCIAL AND PHYSICAL ENVIRONMENTS AND HEALTH DISPARITIES

$595,781
University Of Michigan At Ann Arbor · R01 · FY2004 · ES

Raf 1-ERK cross-talk in Arteriogenesis

$595,775
Michael Simons · Yale University · P01 · FY2015 · HL

Regulation Of Neutral Lipid Metabolism in Adipocytes and other cells.

$595,747
Constantine Londos · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2009 · DK

Neutrophil Survival and Demise During Inflammatory States

$595,727
Harold M Hoffman · Scripps Research Institute, The · P01 · FY2024 · HL

A hypercholesterolemia-induced immunometabolite in atherosclerosis

$595,698
Prediman Krishan Shah · Cedars-Sinai Medical Center · R01 · FY2024 · HL

** AWARDS ISSUED PRIOR TO JANUARY 20, 2025, WERE FUNDED UNDER PREVIOUS ADMINISTRATIONS AND MAY NOT REFLECT THE PRIORITIES AND POLICIES OF THE CURRENT ADMINISTRATION.** CONSUMERS' DEMANDS FOR EGG WHITE DUE TO ITS FAT-FREE, PROTEIN-RICH NATURE HAVE SIGNIFICANTLY INCREASED THE PRODUCTION OF PROCESSED EGG PRODUCTS. HOWEVER, THE UTILIZATION OF ITS COUNTERPART, EGG YOLK, HAS BEEN CONSIDERABLY RESTRICTED BECAUSE OF ITS HIGH LIPID AND CHOLESTEROL CONTENTS AND LIMITED FUNCTIONALITIES. THE IMBALANCED UTILIZATION OF PROCESSED EGG PRODUCTS BECOMES A THREAT TO THE SUSTAINABILITY OF THE EGG INDUSTRY AND PRICE STABILITY FOR CONSUMERS. THEREFORE, NOVEL WAYS SHOULD BE DEVELOPED TO IMPROVE ITS FUNCTIONAL AND NUTRITIONAL PROPERTIES AND CONSEQUENTLY INCREASE THE UTILIZATION OF EGG YOLK. ONE OF THE PROMISING APPROACHES IS TO EMPLOY FRACTIONATION TECHNOLOGY TO PRODUCE EGG YOLK FRACTIONS WITH UNIQUE FUNCTIONAL AND NUTRITIONAL CHARACTERISTICS. OUR LONG-TERM GOAL IS TO DEVELOP NOVEL FUNCTIONAL AND NUTRITIONAL FOOD INGREDIENTS FROM EGG YOLK TO INCREASE ITS USE AND VALUE. THIS PROJECT WILL DEVELOP NOVEL, ENVIRONMENTALLY FRIENDLY, READILY INDUSTRY-APPLICABLE, COST-EFFECTIVE FRACTIONATION TECHNOLOGY FOR EGG YOLK AND PRODUCE DISTINCTIVE EGG YOLK FRACTIONS WITH ENHANCED NUTRITIONAL AND FUNCTIONAL PROPERTIES AS NOVEL FOOD INGREDIENTS, USING PHYSICAL, CHEMICAL, AND ENZYMATIC TREATMENTS. THE FRACTIONATION TECHNOLOGIES UTILIZED IN THIS PROJECT WILL BE SIMPLE, ECONOMICAL, EASY TO SCALE UP, NO USE OF ORGANIC SOLVENTS, AND USE OF CHEMICALS COMPATIBLE WITH HUMAN FOOD, AND COMPATIBILITY FOR A SEQUENTIAL SEPARATION OF EGG YOLK FUNCTIONAL COMPONENTS, AND THEIR OPERATIONAL CONDITIONS WILL BE OPTIMIZED TO PRODUCE EGG YOLK FRACTIONS. SUBSEQUENTLY, THEIR FUNCTIONAL AND NUTRITIONAL PROPERTIES WILL BE ENHANCED USING HIGH-TEMPERATURE-MILD-PRESSURE TREATMENT AND ENZYME HYDROLYSIS. DEVELOPING NOVEL FOOD INGREDIENTS FROM EGG YOLK IN THIS PROJECT WILL CONTRIBUTE TO BALANCING THE USE OF EGG WHITE AND YOLK, AND CONSEQUENTLY IMPROVING THE SUSTAINABILITY AND COMPETITIVENESS OF THE EGG INDUSTRY AND THE PRICE STABILITY OF EGG WHITE FOR FOOD MANUFACTURERS AND CONSUMERS.

$595,400
University Of Maryland Es · · FY2024 · National Institute of Food and Agriculture

Healthy Hearts/ Corazones Saludables: Partnership to promote cardiovascular health in Hispanic and non-Hispanic mothers and children in US home visiting programs

$595,296
Suzanne Phelan · California Poly State U San Luis Obispo · UG3 · FY2022 · HL

Theranostics of Photoreceptor-RPE-Choroid Neurovascular Unit in Eye Diseases:

$595,185
Robert J Zawadzki · University Of California At Davis · R01 · FY2024 · EY

An integrated experimental and computational model of brain microvascular endothelial cell glucose metabolism and transport

$595,104
Alisa M Clyne · University Of Maryland, College Park · · FY2022 · ENG

The Metabolic Impact of Congenital Heterozygous ApoC-III Deficiency in Humans

$595,095
Toni I. Pollin · University Of Maryland Baltimore · R01 · FY2014 · HL